Publication

Abstract : The efficacy of nanoparticles (NPs) in healthcare applications hinges on their biocidal activity and biocompatibility. This research is dedicated to green-synthesized NPs with potent biocidal properties, aiming for high inhibition rates in bacterial infections and offering a multifunctional application, including potential use in anticancer therapy, in comparison to traditional antibiotics. The present study focuses on synthesis of zinc oxide (ZnO) nanoparticles (NPs), including iron-doped ZnO (GZF) and cobalt-doped ZnO (GZC), using the green co-precipitation method involving Psidium guajava (P. guajava) leaf extract. The physicochemical properties of the synthesized NPs were analyzed using various characterization techniques. The antibacterial and anticancer activity depends on the generation of reactive oxygen species (ROS), particle size, surface area, oxygen vacancy, Zn2+ release, and diffusion ability. The antibacterial activity of the synthesized NPs was tested against various Gram-positive (Streptococcus pneumoniae (S. pneumoniae), Bacillus subtilis (B. subtilis) and Gram-negative (Klebsiella pneumoniae (K. pneumoniae), and Pseudomonas aeruginosa (P. aeruginosa) bacterial strains. The zone of inhibition showed higher activity of GZC (18–20 mm) compared to GZF (16–19 mm) and GZO (11–15 mm) NPs. Moreover, anticancer studies against blood cancer cell line (MOLT-4) showed half-maximal inhibitory concentration of 11.3 μg/mL for GZC compared to GZF and GZO NPs with 12.1 μg/mL and 12.5 μg/mL, respectively. Cytotoxicity assessments carried out on the fibroblast L929 cell line indicated that GZO, GZF, and GZC NPs demonstrated cell viabilities of 85.43%, 86.66%, and 88.14%, respectively. Thus, green-synthesized GZC NPs hold promise as multifunctional agents in the biomedical sector.